CD44 and breast carcinoma: CD44 is also a well-known surface biomarker of CSCs, and any anomalous expression or dysregulation of CD44 may indicate tumorigenesis and metastasis in multiple cancers such as colon [10,11,12], bladder [13], gastric [14], lung [15,16], and breast cancers [17,18,19,20,21].